UlcaVis 120 mg Tablets (Bismuth Subcitrate Potassium) is a gastrointestinal medication used to treat and prevent stomach and duodenal ulcers, gastritis, and other acid-related disorders. The active ingredient, bismuth subcitrate potassium, forms a protective barrier over the stomach lining and ulcerated areas, shielding them from the damaging effects of gastric acid while stimulating the natural healing process.
How It Works:
UlcaVis acts locally in the gastrointestinal tract. Bismuth compounds have a cytoprotective effect, meaning they help regenerate damaged mucosal tissue and reduce inflammation. They also exhibit mild antimicrobial properties, including activity against Helicobacter pylori — a common bacterial cause of stomach ulcers. By coating the stomach wall and inhibiting H. pylori growth, UlcaVis supports faster ulcer healing and reduces recurrence.
Indications:
- Peptic ulcer disease (stomach and duodenal ulcers)
- Chronic and acute gastritis
- Indigestion and heartburn related to increased gastric acidity
- Supportive therapy in Helicobacter pylori eradication regimens
Dosage and Administration:
For adults, the typical dosage is 120 mg (1 tablet) taken 2–4 times daily, approximately 30 minutes before meals and at bedtime, or as directed by a healthcare provider. The course usually lasts 4 to 8 weeks, depending on the severity of symptoms.
Precautions:
- Do not use in individuals allergic to bismuth compounds.
- Not recommended for children under 18 years without medical supervision.
- Avoid using concurrently with other bismuth-containing or tetracycline antibiotics without doctor’s advice.
- Temporary darkening of stool or tongue may occur — this effect is harmless and reversible.
Side Effects:
Most patients tolerate UlcaVis well. Mild and temporary side effects may include:
- Dark stool or tongue discoloration
- Mild nausea or constipation
If you experience severe abdominal pain or persistent symptoms, consult your doctor.
Storage:
Store at room temperature, away from moisture and direct sunlight.